Drugs in the Pipeline Novel Intranasal DHE Under Review for Migraine By Diana Ernst, RPh Publish Date January 20, 2021
Safety Alerts and Recalls Potential Med Errors Prompt FDA Action on Vinca Alkaloid Labeling By Diana Ernst, RPh Publish Date January 19, 2021
News Lower Risk of CKD Stage Progression Found With Apixaban By Natasha Persaud Publish Date January 14, 2021
Drugs in the Pipeline Sparsentan Granted Orphan Drug Status for IgA Nephropathy By Brian Park, PharmD Publish Date January 13, 2021
Drugs in the Pipeline Finerenone Gets Priority Review for Diabetic Kidney Disease By Brian Park, PharmD Publish Date January 13, 2021
Drugs in the Pipeline Empagliflozin Under Review for Heart Failure with Reduced Ejection Fraction By Brian Park, PharmD Publish Date January 12, 2021
Drugs in the Pipeline Dapagliflozin Under Review for Chronic Kidney Disease By Brian Park, PharmD Publish Date January 6, 2021
Drugs in the Pipeline FDA Requests Clarification of Data to Complete Roxadustat Review By Diana Ernst, RPh Publish Date December 21, 2020
News IV Iron Products: Adverse Events, Associated Costs Compared By Cassandra Pardini, PharmD Publish Date December 17, 2020
News FDA Approves Oxlumo for Primary Hyperoxaluria Type 1 By Brian Park, PharmD Publish Date November 24, 2020
News New Dosing Option Approved for Imfinzi in NSCLC, Bladder Cancer By Brian Park, PharmD Publish Date November 23, 2020
Drugs in the Pipeline Pegcetacoplan Gets Priority Review for Paroxysmal Nocturnal Hemoglobinuria By Brian Park, PharmD Publish Date November 17, 2020
Drugs in the Pipeline Manufacturing Deficiencies Delay Decision on Sutimlimab for Cold Agglutinin Disease By Brian Park, PharmD Publish Date November 16, 2020
Drugs in the Pipeline Finerenone NDA Submitted for Diabetic Kidney Disease By Brian Park, PharmD Publish Date November 10, 2020
News Novel Medication Relieves Pruritus in Hemodialysis Cases By Jody A. Charnow Publish Date October 29, 2020
News Apabetalone Prevents CV Events in High-Risk Diabetic CKD By Jody A. Charnow Publish Date October 29, 2020
News Nivolumab Plus Cabozantinib Under Review for Renal Cell Carcinoma By Brian Park, PharmD Publish Date October 23, 2020
News FDA Approves New Formulation of Ultomiris for PNH and aHUS By Brian Park, PharmD Publish Date October 14, 2020
Drugs in the Pipeline Dapagliflozin Gets Breakthrough Therapy Status for CKD Indication By Brian Park, PharmD Publish Date October 5, 2020